Novel Isatin-based activator of p53 transcriptional functions in tumor cells
Authors
Abstract:
Bioinorganic medicinal chemistry remains a hot field for research aimed at developing novel anti-cancer treatments. Discovery of metal complexes as potent antitumor chemotherapeutics such as cisplatin led to a significant shift of focus toward organometallic/ bioinorganic compounds containing transition metals and their chelates as novel scaffolds for drug discovery. In that way, transition metal complexes coordinated to essential biological scaffolds represent a highly promising class of compounds for design of novel target-specific therapeutics. Here, we report novel data on p53 activating Isatin-based Cu(II) complex exhibiting cytotoxic properties towards HCT116 and MCF7 tumor cell lines, as confirmed by cell viability assay and flow cytometry analysis of apoptosis. Furthermore, putative p53-mediated mechanism of action of this compound is supported by quantitative analysis of TP53, MDM2 and PUMA genes expression, as well as luciferase-based p53 pathway activation assay. Multiplex immunoassay analysis of inflammatory markers revealed potential modulation of several cytokines and chemokines.
similar resources
The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor
The tumor suppressor, p53, plays critical roles in the cell cycle progression, DNA repair and apoptosis. The PIAS proteins (protein inhibitor of activated STAT) were originally identified as inhibitors of the JAK-STAT pathway. Subsequently, crosstalk between the PIAS proteins and other signaling pathways has been shown to be involved in various cellular processes. Particularly, previous studies...
full textNIAM, a novel activator of p53 and potential tumor suppressor
Post-translational modifications of p53 are critical in modulating its tumor suppressive functions. Ubiquitylation, for example, plays a major role in dictating p53 stability, subcellular localization and transcriptional versus non-transcriptional activities. Less is known about p53 acetylation. It has been shown to govern p53 transcriptional activity, selection of growth inhibitory versus apop...
full textstudy of hash functions based on chaotic maps
توابع درهم نقش بسیار مهم در سیستم های رمزنگاری و پروتکل های امنیتی دارند. در سیستم های رمزنگاری برای دستیابی به احراز درستی و اصالت داده دو روش مورد استفاده قرار می گیرند که عبارتند از توابع رمزنگاری کلیددار و توابع درهم ساز. توابع درهم ساز، توابعی هستند که هر متن با طول دلخواه را به دنباله ای با طول ثابت تبدیل می کنند. از جمله پرکاربردترین و معروف ترین توابع درهم می توان توابع درهم ساز md4, md...
p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene.
The tumour suppressor protein p53 regulates the expression of several genes that mediate cell cycle arrest, apoptosis, DNA repair and other cellular responses. Recently, we have shown that human transcriptional co-activator PC4 is a unique activator of p53 function. In the present study, we report that PC4 is a p53-inducible gene. Bioinformatics analysis reveals multiple p53-binding sites in th...
full textTumor suppressor p53 is a direct transcriptional activator of the human bax gene
The bax gene promoter region contains four motifs with homology to consensus p53-binding sites. In cotransfection assays using p53-deficient tumor cell lines, wild-type but not mutant p53 expression plasmids transactivated a reporter gene plasmid that utilized the bax gene promoter to drive transcription of chloramphenicol acetyltransferase. In addition, wild-type p53 transactivated reporter ge...
full textDeconstructing p53 transcriptional networks in tumor suppression.
p53 is a pivotal tumor suppressor that induces apoptosis, cell-cycle arrest and senescence in response to stress signals. Although p53 transcriptional activation is important for these responses, the mechanisms underlying tumor suppression have been elusive. To date, no single or compound mouse knockout of specific p53 target genes has recapitulated the dramatic tumor predisposition that charac...
full textMy Resources
Journal title
volume 8 issue 3
pages 119- 128
publication date 2019-09-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023